Adat Chaverim – Congregation for Humanistic Judaism High Holiday Celebration: Cantor Jonathan Friedman leads the combined High Holiday celebration, 2 p.m. Cost $50; $15 ages 12 and younger.

Source: https://www.dailynews.com/2023/09/09/religion-events-in-the-san-fernando-valley-area-sept-9-16-2/

A number of other institutional investors and hedge funds have also bought and sold shares of K. Cantor Fitzgerald Investment Advisor L.P increased its holdings in Kellanova by 95.3% in the first quarter.

Source: https://www.dailypolitical.com/2023/11/19/dimensional-fund-advisors-lp-has-164-79-million-stake-in-kellanova-nysek.html

Cantor Fitzgerald also issued estimates for Aclaris Therapeutics’ FY2024 earnings at ($1.59) EPS.

Source: https://www.dailypolitical.com/2023/11/09/fy2023-eps-estimates-for-aclaris-therapeutics-inc-increased-by-cantor-fitzgerald-nasdaqacrs.html

Cantor Fitzgerald assumed coverage on shares of CVS Health in a research report on Thursday.

Source: https://www.etfdailynews.com/2023/04/23/cfo4life-group-llc-has-631000-stock-position-in-cvs-health-co-nysecvs/

Cantor Fitzgerald began coverage on Alector in a research note on Friday, September 22nd.

Source: https://www.etfdailynews.com/2023/12/17/alector-nasdaqalec-upgraded-at-stifel-nicolaus/

Cantor Fitzgerald began coverage on Datadog in a research report on Wednesday, January 25th.

Source: https://www.etfdailynews.com/2023/02/05/datadog-inc-nasdaqddog-shares-sold-by-russell-investments-group-ltd/

Cantor Fitzgerald & Co. is acting as the sole book-running manager for the public offering.

Source: https://investorplace.com/2023/05/why-is-ocugen-ocgn-stock-down-22-today/

Cantor Fitzgerald cut Reata Pharmaceuticals from an “overweight” rating to a “neutral” rating in a research note on Friday.

Source: https://www.etfdailynews.com/2023/07/30/reata-pharmaceuticals-nasdaqreta-downgraded-by-guggenheim/

Cantor Fitzgerald cut shares of Coursera from an “overweight” rating to a “neutral” rating and cut their price objective for the stock from $17.00 to $16.00 in a report on Friday, February 10th.

Source: https://www.etfdailynews.com/2023/02/22/coursera-inc-nysecour-shares-acquired-by-exoduspoint-capital-management-lp/

Cantor Fitzgerald decreased their price objective on Cloudflare from $65.00 to $50.00 in a research note on Friday, April 28th.

Source: https://www.etfdailynews.com/2023/07/02/ae-wealth-management-llc-reduces-holdings-in-cloudflare-inc-nysenet/

Cantor Fitzgerald increased their price objective on shares of Catalyst Pharmaceuticals from $22.00 to $25.00 in a research note on Friday, March 17th.

Source: https://www.etfdailynews.com/2023/06/10/commonwealth-of-pennsylvania-public-school-empls-retrmt-sys-grows-holdings-in-catalyst-pharmaceuticals-inc-nasdaqcprx/

Cantor Fitzgerald increased their price target on shares of Palo Alto Networks from $240.00 to $250.00 and gave the company an “overweight” rating in a research report on Monday, August 21st.

Source: https://www.americanbankingnews.com/2023/09/21/ae-wealth-management-llc-boosts-stock-holdings-in-palo-alto-networks-inc-nasdaqpanw.html

Cantor Fitzgerald Investment Advisor L.P boosted its holdings in Merck & Co., Inc. by 94.2% in the 1st quarter.

Source: https://www.americanbankingnews.com/2023/01/03/crumly-associates-inc-sells-103-shares-of-merck-co-inc-nysemrk.html

Cantor Fitzgerald Investment Advisor L.P increased its stake in shares of JPMorgan Chase & Co. by 81.1% in the 1st quarter.

Source: https://www.etfdailynews.com/2023/07/16/first-merchants-corp-acquires-5324-shares-of-jpmorgan-chase-co-nysejpm/

Cantor Fitzgerald Investment Advisor L.P lifted its stake in JPMorgan Chase & Co. by 81.1% during the first quarter.

Source: https://www.etfdailynews.com/2023/01/08/jpmorgan-chase-co-nysejpm-shares-sold-by-sage-rhino-capital-llc/

Cantor Fitzgerald raised their price target on Acadia Healthcare from $83.00 to $85.00 and gave the company a “neutral” rating in a research report on Thursday, September 14th.

Source: https://www.americanbankingnews.com/2023/11/14/acadia-healthcare-company-inc-nasdaqachc-director-debra-k-osteen-sells-15000-shares.html

Cantor Fitzgerald raised their price target on MannKind from $6.50 to $7.50 and gave the stock an “overweight” rating in a research note on Tuesday, August 8th.

Source: https://www.dailypolitical.com/2023/11/11/fy2025-eps-estimates-for-mannkind-co-nasdaqmnkd-reduced-by-hc-wainwright.html

Cantor Fitzgerald reaffirmed an “overweight” rating and set a $136.00 price objective on shares of Neurocrine Biosciences in a research note on Tuesday.

Source: https://www.etfdailynews.com/2023/08/25/insider-selling-neurocrine-biosciences-inc-nasdaqnbix-cfo-sells-2132-shares-of-stock/

Cantor Fitzgerald reduced their target price on shares of Lucid Group from $18.00 to $13.00 and set an “overweight” rating for the company in a research note on Thursday, February 23rd.

Source: https://www.etfdailynews.com/2023/04/04/31534-shares-in-lucid-group-inc-nasdaqlcid-acquired-by-veriti-management-llc/

Cantor Fitzgerald reissued an “overweight” rating and issued a $10.00 price target on shares of AvePoint in a research report on Monday, September 18th.

Source: https://www.etfdailynews.com/2023/10/04/avepoint-nasdaqavpt-trading-3-3-higher/